ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, featuring promising improvements across various clinical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, much more trusted alternative for therapeutic use, specific